LGG clinical trials at UCSF
1 research study open to eligible people
LGG means low-grade glioma, a type of brain tumor that progresses slowly. UCSF has ongoing research to check how safe and effective FORE8394 is in people with cancer and BRAF gene alterations. This study includes participants with these gene changes.
FORE8394 in Participants With Cancer Harboring BRAF Alterations
open to eligible people ages 10 years and up
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with locally advanced or metastatic solid tumors, or recurrent or progressive primary central nervous system (CNS) tumors harboring BRAF fusions, or in participants with rare BRAF V600-mutated solid tumors, melanoma, thyroid, or recurrent primary CNS tumors.
San Francisco, California and other locations
Last updated: